Friday, May 1, 2020

DSCSA Exemption And Exclusion For COVID-19 | FDA Guidance

Open the complete guidance:  Exemption and Exclusion from Certain Requirements of the Drug Supply Chain Security Act During the COVID-19 Public Health Emergency - FDA Guidance (PDF)

According to the guidance document:

"Due to the COVID-19 pandemic, FDA has been monitoring requests related to provisions of the Drug Supply Chain Security Act (DSCSA) because the provisions may affect the prescription drug supply chain during the COVID-19 outbreak. FDA is issuing this guidance to clarify the scope of the public health emergency exemption and exclusion under the DSCSA for the duration of the public health emergency declared by the Secretary of Health and Human Services (HHS)" . . .

Return Home:  The Designated Representative and Exemptee Blog

-------------

California Designated Representative Training Programs - Board-Approved - For wholesalers, 3PL, reverse distributors - Earns a training affidavit
California Designated Representative Training Programs - Board-Approved - For wholesalers, 3PL, reverse distributors - Earns a training affidavit

For Designated Representative license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training affidavit):
     Florida:

For HMDR Exemptee license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training completion certificate):

1 comment:

Custom Search

From SkillsPlus International Inc.